Managing Blood Cancer or a Bone Marrow Transplant Amid COVID-19

Share
Print
Sergio Giralt

Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.  A team of experts at MSK shared their insights on this topic in an Information Session specifically for those with a blood cancer diagnosis.  

Members of the MSK community joined the session to have their most pressing questions answered. Topics ranged from what makes someone immunocompromised, to how to best manage a bone marrow transplant and what to expect when coming to MSK.  The event was hosted by Sergio Giralt, MD, Deputy Division Head, Division of Hematologic Malignancies at MSK and featured other experts in all areas of blood cancers. The panelists addressed the latest research and treatment options in the areas of Leukemia, Lymphoma, Multiple Myeloma and stem cell transplant.

MSK plans to continue these Patient Information Sessions on a regular basis to help address concerns from our larger community on a variety of cancer-related issues.  Information on upcoming sessions and a recording of previous sessions can be heard on our website here.